サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434513

にきび治療薬市場：にきびタイプ、薬剤クラス別、薬剤タイプ、投与経路別- 世界予測2024-2030年

Acne Drugs Market by Acne Type (Comedonal, Cystic, Inflammatory), Drug Class (Antibiotics, Combination Drugs, Hormonal Agents), Drug Type, Route of Administration - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
にきび治療薬市場：にきびタイプ、薬剤クラス別、薬剤タイプ、投与経路別- 世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

にきび治療薬市場規模は2023年に59億6,000万米ドルと推計され、2024年には63億2,000万米ドルに達し、CAGR 6.23%で2030年には91億米ドルに達すると予測されます。

にきび治療薬の世界市場

主な市場の統計
基準年[2023］ 59億6,000万米ドル
予測年[2024］ 63億2,000万米ドル
予測年 [2030] 91億米ドル
CAGR（%） 6.23%
にきび治療薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはにきび治療薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、にきび治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-にきび治療薬市場の市場規模および予測は？

2-にきび治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-にきび治療薬市場における技術動向と規制の枠組みは？

4-にきび治療薬市場における主要ベンダーの市場シェアは？

5-にきび治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で皮膚関連疾患の発生率が増加
      • 皮膚の健康に対する意識の高まりと、個別の個別治療への傾向
      • eコマースプラットフォームでのにきび治療薬の利用可能性の向上
    • 抑制要因
      • スキンケア薬の多数の代替品の利用可能性
    • 機会
      • 改良および強化されたにきび治療薬のイントロダクション
      • 併用療法に対する新たな需要
    • 課題
      • 化粧品承認における厳しい規制と複雑なプロセス
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 にきび治療薬市場ニキビの種類別

  • 面皰
  • 嚢胞性
  • 炎症性
  • 術後/創傷

第7章 にきび治療薬市場薬剤クラス別

  • 抗生物質
  • 配合剤
  • ホルモン剤
  • レチノイド

第8章 にきび治療薬市場薬剤の種類別

  • 一般用医薬品
  • 処方薬

第9章 にきび治療薬市場：投与経路別

  • 注射可能
  • オーラル
  • 話題

第10章 南北アメリカのにきび治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のにきび治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのにきび治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AbbVie Inc.
    • Almirall, S.A.
    • Amgen, Inc.
    • Apotex Inc.
    • Arctic Therapeutics
    • Bausch Health Companies Inc.
    • Bayer AG
    • BioPharmX, Inc.
    • Cipher Pharmaceuticals Inc.
    • Daiichi Sankyo Company, Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • F. Hoffmann-La Roche AG
    • Galderma S.A.
    • Intas Pharmaceuticals Ltd.
    • Johnson & Johnson Services, Inc.
    • Mayne Pharma Group Limited
    • Midas Pharma GmbH
    • Mylan N.V
    • Novartis AG
    • Pfizer Inc.
    • Skinvisible Pharmaceuticals, Inc.
    • Stiefel Laboratories, Inc. by GSK Group
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ACNE DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ACNE DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACNE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACNE DRUGS MARKET DYNAMICS
  • FIGURE 7. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 10. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 12. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 14. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACNE DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACNE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACNE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACNE DRUGS MARKET SIZE, BY COMEDONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACNE DRUGS MARKET SIZE, BY CYSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACNE DRUGS MARKET SIZE, BY INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ACNE DRUGS MARKET SIZE, BY POSTSURGICAL/WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 11. ACNE DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACNE DRUGS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ACNE DRUGS MARKET SIZE, BY HORMONAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ACNE DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ACNE DRUGS MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ACNE DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 19. ACNE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ACNE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ACNE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ACNE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACNE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ACNE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ACNE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. ACNE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 191. ACNE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ACNE DRUGS MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA051B6

[192 Pages Report] The Acne Drugs Market size was estimated at USD 5.96 billion in 2023 and expected to reach USD 6.32 billion in 2024, at a CAGR 6.23% to reach USD 9.10 billion by 2030.

Global Acne Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.96 billion
Estimated Year [2024] USD 6.32 billion
Forecast Year [2030] USD 9.10 billion
CAGR (%) 6.23%
Acne Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acne Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acne Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acne Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almirall, S.A., Amgen, Inc., Apotex Inc., Arctic Therapeutics, Bausch Health Companies Inc., Bayer AG, BioPharmX, Inc., Cipher Pharmaceuticals Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Galderma S.A., Intas Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Mayne Pharma Group Limited, Midas Pharma GmbH, Mylan N.V, Novartis AG, Pfizer Inc., Skinvisible Pharmaceuticals, Inc., Stiefel Laboratories, Inc. by GSK Group, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acne Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Acne Type
    • Comedonal
    • Cystic
    • Inflammatory
    • Postsurgical/Wound
  • Drug Class
    • Antibiotics
    • Combination Drugs
    • Hormonal Agents
    • Retinoids
  • Drug Type
    • OTC Drugs
    • Prescription Drugs
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acne Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acne Drugs Market?

3. What are the technology trends and regulatory frameworks in the Acne Drugs Market?

4. What is the market share of the leading vendors in the Acne Drugs Market?

5. Which modes and strategic moves are suitable for entering the Acne Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Acne Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of skin-related diseases in individuals worldwide
      • 5.1.1.2. Growing awareness regarding skin health and inclination toward specific personalized treatments
      • 5.1.1.3. Increasing availability of acne drugs on eCommerce platforms
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of numerous alternatives for skin care drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of improved and enhanced acne drugs
      • 5.1.3.2. Emerging demand for combination therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and complicated processes in the approval of cosmetic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Acne Drugs Market, by Acne Type

  • 6.1. Introduction
  • 6.2. Comedonal
  • 6.3. Cystic
  • 6.4. Inflammatory
  • 6.5. Postsurgical/Wound

7. Acne Drugs Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Combination Drugs
  • 7.4. Hormonal Agents
  • 7.5. Retinoids

8. Acne Drugs Market, by Drug Type

  • 8.1. Introduction
  • 8.2. OTC Drugs
  • 8.3. Prescription Drugs

9. Acne Drugs Market, by Route of Administration

  • 9.1. Introduction
  • 9.2. Injectable
  • 9.3. Oral
  • 9.4. Topical

10. Americas Acne Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Acne Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Acne Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AbbVie Inc.
    • 14.1.2. Almirall, S.A.
    • 14.1.3. Amgen, Inc.
    • 14.1.4. Apotex Inc.
    • 14.1.5. Arctic Therapeutics
    • 14.1.6. Bausch Health Companies Inc.
    • 14.1.7. Bayer AG
    • 14.1.8. BioPharmX, Inc.
    • 14.1.9. Cipher Pharmaceuticals Inc.
    • 14.1.10. Daiichi Sankyo Company, Ltd.
    • 14.1.11. Dr. Reddy's Laboratories Ltd.
    • 14.1.12. F. Hoffmann-La Roche AG
    • 14.1.13. Galderma S.A.
    • 14.1.14. Intas Pharmaceuticals Ltd.
    • 14.1.15. Johnson & Johnson Services, Inc.
    • 14.1.16. Mayne Pharma Group Limited
    • 14.1.17. Midas Pharma GmbH
    • 14.1.18. Mylan N.V
    • 14.1.19. Novartis AG
    • 14.1.20. Pfizer Inc.
    • 14.1.21. Skinvisible Pharmaceuticals, Inc.
    • 14.1.22. Stiefel Laboratories, Inc. by GSK Group
    • 14.1.23. Sun Pharmaceutical Industries Limited
    • 14.1.24. Teva Pharmaceutical Industries Ltd.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing